February 3, 2026

Azenta, Inc. (AZTA) Stock Analysis: Exploring a 15.91% Upside Potential in the Healthcare Sector

Azenta, Inc. (NASDAQ: AZTA), a prominent player in the healthcare sector, operates within the medical instruments and supplies industry. With a market capitalization of $1.73 billion, this Burlington, Massachusetts-based company..

ARS Pharmaceuticals, Inc. (SPRY) Stock Analysis: Eyeing a 171% Upside with Innovative Allergy Solutions

ARS Pharmaceuticals, Inc. (NASDAQ: SPRY), a dynamic player in the biotechnology sector, has been capturing investor attention with its pioneering approach to treating severe allergic reactions. Headquartered in San Diego,..

Tarsus Pharmaceuticals, Inc. (TARS) Stock Analysis: Unpacking a 33% Potential Upside Amid Biotech Growth

Investors with a keen eye on the healthcare sector may find Tarsus Pharmaceuticals, Inc. (NASDAQ: TARS) an intriguing candidate, given its promising pipeline and significant potential upside. This commercial-stage biopharmaceutical..

Dynavax Technologies Corporation (DVAX) Stock Analysis: Unveiling a 42% Potential Upside in a Dynamic Biotech Sector

Dynavax Technologies Corporation (NASDAQ: DVAX) is making waves in the healthcare sector, with its strategic focus on vaccine development and commercialization. As a prominent player in the biopharmaceutical industry, Dynavax..

Biohaven Ltd. (BHVN) Stock Analysis: Exploring a 77% Potential Upside for Investors

Biohaven Ltd. (NYSE: BHVN), a biotechnology company focused on innovative therapies in immunology, neuroscience, and oncology, presents a fascinating case for investors seeking potential high returns in the healthcare sector...

QuidelOrtho Corporation (QDEL): An Investor’s Look at a 38.64% Potential Upside in the Healthcare Sector

QuidelOrtho Corporation (NASDAQ: QDEL), a prominent player in the medical devices industry, has captured investor attention with its strategic focus on diagnostic testing solutions. Headquartered in San Diego, California, the..

GRAIL, Inc. (GRAL) Investor Outlook: A Healthcare Innovator with 10.93% Upside Potential

GRAIL, Inc. (NASDAQ: GRAL) is making headlines in the healthcare sector with its promising advances in multi-cancer early detection technology. As a commercial-stage company specializing in diagnostics and research, GRAIL..

Liquidia Corporation (LQDA) Stock Analysis: A Biotech Challenger with Impressive Revenue Growth

Liquidia Corporation (NASDAQ: LQDA), a biopharmaceutical firm based in Morrisville, North Carolina, has become a focal point for investors in the healthcare sector. As a biotechnology company, Liquidia is dedicated..

Bausch Health Companies Inc. (BHC): Investor Outlook with a 28.97% Potential Upside

Bausch Health Companies Inc. (NYSE: BHC), a key player in the healthcare sector, particularly in the specialty and generic drug manufacturing industry, has been capturing attention with its notable potential..

Vera Therapeutics, Inc. (VERA) Stock Analysis: Exploring a 65.98% Potential Upside for a Biotech Innovator

Vera Therapeutics, Inc. (NASDAQ: VERA) is capturing the attention of individual investors and analysts alike, driven by its promising pipeline and a striking potential upside of 65.98%. As a clinical-stage..

Janux Therapeutics, Inc. (JANX) Stock Analysis: Exploring a Potential Upside of 354.53% with Innovative Cancer Therapies

Janux Therapeutics, Inc. (NASDAQ: JANX), a promising player in the biotechnology sector, is capturing investor attention with its innovative approach to cancer treatment and a staggering potential upside of 354.53%...

National HealthCare Corporation (NHC) Stock Analysis: A Deep Dive into a Resilient Healthcare Player

National HealthCare Corporation (NYSE: NHC), a key player in the healthcare sector, has carved a niche for itself in the medical care facilities industry with a market capitalization of $2.32..

Arcutis Biotherapeutics, Inc. (ARQT) Stock Analysis: Exploring a 24% Upside Potential in the Booming Biotech Sector

Investors with a keen eye on the biotechnology sector may find Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) an intriguing prospect, given its strong growth potential and innovative pipeline. With a market..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: Exploring a 10% Potential Upside in Healthcare Plans

Alignment Healthcare, Inc. (ALHC) is gaining attention in the healthcare sector, particularly for its focus on transforming senior healthcare through innovative Medicare Advantage plans. Headquartered in Orange, California, the company..

Surgery Partners, Inc. (SGRY) Stock Analysis: Exploring a 71.99% Potential Upside

Surgery Partners, Inc. (NASDAQ: SGRY) is making waves in the healthcare sector, specifically within the medical care facilities industry. With a market capitalization of $1.91 billion, the company holds a..

HUTCHMED (China) Limited (HCM) Stock Analysis: Exploring a 44.9% Potential Upside Amidst Healthcare Innovations

HUTCHMED (China) Limited (HCM), a prominent player in the healthcare sector, stands at the forefront of innovation in the field of targeted therapeutics and immunotherapies. Specializing in the treatment of..

Ascentage Pharma Group Internat (AAPG) Stock Analysis: Assessing a Potential 97.3% Upside for Biotechnology Investors

Ascentage Pharma Group International (AAPG), a prominent player in the biotechnology sector, is drawing significant attention from investors due to a compelling potential upside of 97.3%. Headquartered in Suzhou, China,..

Neogen Corporation (NEOG) Stock Analysis: Healthcare Diagnostics Firm with 13.82% Upside Potential

Neogen Corporation (NASDAQ: NEOG), a key player in the healthcare sector specializing in diagnostics and research, is drawing investor attention with its impressive potential upside of 13.82%. Operating primarily in..

Addus HomeCare Corporation (ADUS) Investor Outlook: A 33.88% Potential Upside Beckons

Investors eyeing opportunities in the healthcare sector might find Addus HomeCare Corporation (ADUS) an appealing prospect. With a focus on providing comprehensive personal care, hospice, and home health services, the..

Teladoc Health, Inc. (TDOC) Investor Outlook: Is the 66% Upside Within Reach?

Teladoc Health, Inc. (NYSE: TDOC), a leader in virtual healthcare services, has captured investor attention with its significant potential upside of 66.33%. Despite current challenges, the company represents a compelling..

Search

Funds

February 3, 2026

Search

Funds

February 3, 2026

FTSE 100

Funds